Chongqing Huabang Pharmaceutical Co., Ltd. (002004)

Chongqing Huabang Pharmaceutical Co., Ltd. (002004)

Chongqing Huabang Pharmaceutical Co., Ltd. was established in September, 1994, and is a wholly-owned subsidiary of the listed parent company of China State life health Co., Ltd. (Shenzhen code 002004). The registered capital of Huabang pharmaceutical is 450 million yuan, with a total asset of 3.58 billion yuan, more than 1500 employees, holding a number of wholly-owned subsidiaries and subsidiaries such as Huabang Shengkai Pharmaceutical Co., Ltd.

The company is located in Liangjiang New District, Chongqing, with more than 260 Mu garden type work park. The Chinese people "protect human health with high quality products" as the highest vision of the enterprise, and are committed to the research and development, production and customer service of pharmaceutical products. The company mainly focuses on the fields of skin and tuberculosis, including retinoic acid drugs, anti allergy, antifungal and glucocorticoids. After years of development, Huabang has become a professional skin service provider, and has a large market share in the field of anti TB drugs. Preparations and API products are sold to many overseas markets.

China state is market oriented, and meets all kinds of health needs of customers through technological innovation, high-quality products and professional customer service. Chinese are striving to become the first-class pharmaceutical enterprises in China!

Over the past 20 years, the company has been committed to "high-quality products, healthy life", and has established a good reputation in the field of skin and tuberculosis. At the same time, the company has been introverted in the research and development of new drugs, and has accumulated a large number of heavy drugs in the fields of "respiration, cardio cerebrovascular, blood, tumor" and so on.

In the future, the company will continue to implement the compound promotion mode of "self-operation of skin and tuberculosis drugs, cooperative promotion of other drugs", and at the same time, we will integrate advanced models and concepts of the industry, and jointly fulfill the ultimate responsibility and mission of "satisfying clinical, serving patients and being faithful to human health"!

>> Polycore Tubing